Paras Healthcare (Mainboard IPO)
📅 Dates: 21 - 23 Oct• 💰 Issue Size: ₹1450 Cr.Complete guide to Paras Healthcare Mainboard IPO: latest Grey Market Premium (GMP), live bidding subscription status, price band, lot size, financial report, and investment analysis.
📊 Overview & Key Highlights
| Parameter | Details |
|---|---|
| Issue Type | Mainboard IPO (BSE, NSE) |
| Issue Dates | 21 - 23 Oct |
| Price Band | ₹660 to ₹693 |
| Total Issue Size | 2,09,23,520 shares (agg. up to ₹1,450 Cr) |
| Minimum Market Lot | 21 shares (Min. Inv: ₹14,553) |
| Current GMP | ₹15 (Est. Listing: ₹708 (2.16%)) (Updated: 22 Oct, 15:15) |
| Subscription Status | 0.36x (Updated: 22 Oct, 17:33) |
| Investor Demand Rating | ⭐⭐☆☆☆ (2/5 - Low / Mild Demand) |
📈 Live Subscription Demand
| Category | Subscription Multiplier (x) |
|---|---|
| Qualified Institutional (QIB) | 0.07x |
| Non-Institutional / HNI | 0.26x |
| Retail Individual (RII) | 1.37x |
| Total Subscription | 0.36x (Updated: 22 Oct, 17:33) |
Live QIB, NII / HNI, and Retail subscription multipliers will update automatically here once bidding begins.
🎯 Investment Analysis & Verdict
📌 Business Model & Revenue Streams
Paras Healthcare runs a network of multi-specialty tertiary care hospitals, earning revenue through inpatient admissions, surgical procedures, and outpatient consultations across critical specialties like cardiology, oncology, and neurosciences. Patients pay directly out-of-pocket or via private health insurance providers and government-backed healthcare schemes.🚀 Key Strengths & Growth Drivers
• Early Mover in Under-Penetrated Markets: Strong foothold in underserved tier-2 and tier-3 pockets across North and East India (especially Bihar and Jharkhand) where quality tertiary care competition is far thinner than crowded metros.• Rapid Capacity Ramp-Up: Bed count expanded aggressively from 1,250 to 2,135 in just two years, creating immediate operating leverage as newer facilities mature and occupancy levels climb.
• Balanced High-Value Specialty Mix: Focus on complex, high-margin procedures—like cardiac surgery and joint replacements—drives healthier average revenue per occupied bed (ARPOB).
⚠️ Key Risks & Red Flags
• Heavy Regional Concentration: A massive chunk of footfalls and revenue is tied to a handful of clusters in North India and Bihar, leaving financial performance vulnerable to local regulatory, socio-economic, or pricing disruptions.• Gestation Drag from New Beds: Adding nearly 900 beds in a short window comes with heavy initial operating overheads; slow ramp-up or lower occupancy in newer centers can severely squeeze near-term margins.
• Talent Retention in Tier-2/3 Hubs: Attracting and retaining experienced specialist doctors and skilled nursing staff in non-metro locations is inherently tough and keeps staff attrition and personnel costs under constant pressure.
🎯 Retail Verdict
Using issue proceeds to wipe out around ₹375 crore of debt will immediately relieve interest drag and clean up the balance sheet. While the long-term tier-2 healthcare thesis is fundamentally solid, newly added hospital capacity takes time to turn cash-flow accretive, making this better suited as a patient long-term bet rather than a surefire candidate for quick listing-day gains. Moderate-risk investors looking for a regional healthcare compounder can consider tracking post-listing execution and occupancy ramp-up closely.📅 Tentative Timetable
| Event | Tentative Date |
|---|---|
| IPO Open | Wed, Oct 21, 2026 |
| IPO Close | Fri, Oct 23, 2026 |
| Allotment | Mon, Oct 26, 2026 |
| Refund | Tue, Oct 27, 2026 |
| Credit of Shares | Tue, Oct 27, 2026 |
| Listing | Wed, Oct 28, 2026 |
💼 Market Lot & Investment Sizing
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 21 | ₹14,553 |
| Retail (Max) | 13 | 273 | ₹1,89,189 |
| S-HNI (Min) | 14 | 294 | ₹2,03,742 |
| S-HNI (Max) | 68 | 1428 | ₹9,89,604 |
| B-HNI (Min) | 69 | 1449 | ₹10,04,157 |
💰 Financial Summary
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹1151.02 | ₹1144.39 | ₹15.33 | ₹1477.66 |
| 2023 | ₹1314.21 | ₹1364.24 | ₹57.98 | ₹1810.45 |
| 2024 | ₹1628.78 | ₹1552.75 | ₹43.83 | ₹2071.14 |
🏢 About Paras Healthcare
Established in 1987, Paras Healthcare Limited is one of the leading regional hospital chains operating across North India, Bihar, and Jharkhand. The company focuses on expanding specialized, cost-effective healthcare infrastructure into tier-2 and tier-3 cities under its 'Paras Health' brand. Its clinical specialties encompass cardiac sciences, oncology, neurosciences, gastroenterology, and orthopedics with joint replacements.As of March 31, 2024, the network operates eight multidisciplinary hospitals across Haryana, Bihar, Rajasthan, Jharkhand, Uttar Pradesh, and Jammu & Kashmir, with aggregate capacity growing from 1,250 beds in March 2022 to 2,135 beds. Clinical and operational care across these facilities is supported by a workforce of 1,091 physicians and 1,509 nursing professionals.
🎯 Objects of the Issue
• • • Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings availed by the Company::: ₹320.90 Cr• • • Investment in wholly owned subsidiary, PMHPL, for full or partial repayment/prepayment of its borrowings::: ₹54.10 Cr
📬 Registrar & Allotment Information
MUFG Intime India Private Ltd Phone: +91-22-4918 6270 Email: parashealthcare.ipo@linkintime.co.in Website:💬 Community Discussion & Views
Are you planning to apply for the Paras Healthcare IPO? Share your bidding strategy, allotment status, or listing expectations with fellow investors in the replies below!👉 Browse all upcoming Mainboard & SME IPOs on UNP
Disclaimer: All IPO details provided above are for educational and informational purposes only. Readers are advised to consult their financial advisors and review the Red Herring Prospectus (RHP) before investing.
📌 Thread Quick Navigation: Post #2: Live & Historic GMP | Post #3: Subscription Stats | Post #4: Allotment Status | Post #5: Listing Debut | Post #6: Community & Social Reviews
Last edited: